Key result
Intravenous chlorpromazine elevates PRA and aldosterone levels in schizophrenic patients.
Why the study?
Does intravenous chlorpromazine affect plasma renin activity and aldosterone levels in schizophrenic patients?
Does intravenous chlorpromazine affect plasma renin activity and aldosterone levels in schizophrenic patients?
Intravenous chlorpromazine increases plasma renin activity and aldosterone levels, which may confound the clinical evaluation of the renin-angiotensin-aldosterone system in patients receiving this medication.
Answers are grounded in this paper and cite their sources.
May confound RAAS evaluation in chlorpromazine-treated patients; leaves open generalizability beyond this schizophrenic cohort.
The response of plasma renin activity (PRA) and aldosterone to the intravenous administration of chlorpromazine was determined in schizophrenic patients while they were supine and on a normal sodium diet. In all subjects PRA and aldosterone increased during chlorpromazine administration with little or no change in blood pressure. The maximum PRA and aldosterone levels occurred 60 min after the higher dose of chlorpromazine. These data suggest that chlorpromazine affects the renin-angiotensin-aldosterone system and it may interfere with the evaluation of this system in patients receiving this drug.
No takes yet. Share an insight, caveat, or question.
Robertson et al. (1975) studied Schizophrenia. Chlorpromazine was evaluated on Plasma renin activity (PRA) and aldosterone levels. Intravenous administration of chlorpromazine increased plasma renin activity and aldosterone levels in schizophrenic patients, with maximum levels occurring 60 minutes after the higher dose.
Synapse has enriched 10 related papers. Consider them for comparative context: